Home/Filings/4/0000899243-22-021398
4//SEC Filing

Matthews Christine 4

Accession 0000899243-22-021398

CIK 0001587221other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 7:39 PM ET

Size

5.0 KB

Accession

0000899243-22-021398

Insider Transaction Report

Form 4
Period: 2022-06-06
Matthews Christine
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2022-06-06$0.71/sh82$584,183 total
Footnotes (2)
  • [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to restricted stock units of the Issuer.
  • [F2]Reflects a 1-for-35 reverse stock split of the Issuer's common stock, effected on April 11, 2022.

Issuer

Zosano Pharma Corp

CIK 0001587221

Entity typeother

Related Parties

1
  • filerCIK 0001799864

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 7:39 PM ET
Size
5.0 KB